Prediction Case File
YouTubeEvaluation Complete

Friends! In this video, I'm going to do an AMD stock analysis and talk about the risks and upside potential of AMD stock

1 extracted signal · 1 resolved · 0 still active

The Patient Investor profile imageThe Patient Investor05 Aug 2025, 21:47 UTC
Video preview for Friends! In this video, I'm going to do an AMD stock analysis and talk about the risks and upside potential of AMD stock
Signals
1
Eligible signals in this source
Open
0
Still being tracked
Resolved
1
Evaluable outcomes
Successful
1
Canonical correct result
Failed
0
Canonical failed result
Resolved success
100%
Open and excluded signals omitted
Source overview

AI-generated source summary

The analysis is based on AMD's Q2 2025 financial results. Earnings per share missed estimates at 48 cents adjusted versus 49 cents expected. Revenue beat expectations at $7.69 billion versus $7.42 billion expected. Guidance for the third quarter is strong, expecting sales of $8.7 billion plus or minus $300 million, versus analyst expectations of $8.3 billion. Revenue growth was 32% year-on-year. Non-GAAP gross margins decreased from 53% to 43%. Operating income and earnings per share on a non-GAAP basis also declined year-on-year. The data center business revenue was weak but client and gaming segments showed 69% overall growth. Chip export restrictions to China had a negative impact of $800 million in the June quarter. The speaker said shipments expected to resume waivers potentially being approved. The guidance does not include China revenues. The speaker provided a valuation model with an earnings per share of $3.96 for 2025, 48% growth for 2026 and 20% from 2027 to 2030 with a PE ratio of 30 times implying a $364.59 target.

AI-generated summary based on the source content.

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  3. Market predictions extracted

    1 eligible signal linked to this case.

  4. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

  5. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  6. Case evaluation completed

    All evaluable predictions in this case reached terminal outcomes.

Extracted intelligence

Signals in this source

Continue the evidence trail
Analyst history

The Patient Investor

Tracked signals
292
Historical success
32.9%
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.